Christian M M, Murphy C M, Wagner R F
Department of Dermatology, University of Texas Medical Branch at Galveston, USA.
Dermatol Surg. 1998 Oct;24(10):1151-3. doi: 10.1111/j.1524-4725.1998.tb04089.x.
Metastatic basal cell carcinoma (MBCC) is rare, occurring in only 0.0028-0.55% of all basal cell carcinomas (BCCs). Patients with MBCC may present with a variety of findings, related to the site of metastasis.
Clinical presentation of a MBCC that became symptomatic due to unilateral lymphedema and a review of the relevant literature.
Case report with literature review.
Patients may present with lymphadenopathy, ulcerations, anemia, bone pain, or muscle weakness related to the site of metastasis. In this reported case, MBCC presented as unilateral lymphedema. Risk factors for MBCC include radiation, large and invasive tumors, and a history of recurrence. The average survival time for localized lymph node metastasis in BCC is 3.6 years. This patient is currently 2 years since MBCC presentation and is currently without evidence of recurrence.
To our knowledge, we report the first case of MBCC that presented as unilateral lymphedema.
转移性基底细胞癌（MBCC）较为罕见，仅占所有基底细胞癌（BCC）的0.0028 - 0.55%。MBCC患者可能会出现与转移部位相关的多种表现。
报告一例因单侧淋巴水肿出现症状的MBCC的临床表现，并对相关文献进行综述。
病例报告及文献综述。
患者可能出现与转移部位相关的淋巴结病、溃疡、贫血、骨痛或肌肉无力。在本报告病例中，MBCC表现为单侧淋巴水肿。MBCC的危险因素包括放疗、巨大侵袭性肿瘤和复发史。BCC局部淋巴结转移的平均生存时间为3.6年。该患者自MBCC出现以来已过去2年，目前无复发迹象。
据我们所知，我们报告了首例表现为单侧淋巴水肿的MBCC病例。
